Press Releases

ROCHELLE PARK, NJ—January 12, 2022 – i3 Health and Oncology Data Advisor have announced that ODACon, a Rare Hematologic Malignancies Symposium, will be held on January 29, 2022. This 1-day virtual conference features 5 exclusive sessions on emerging data in hematologic malignancies, including acute lymphoblastic leukemia (ALL), Hodgkin lymphoma (HL), mantle cell lymphoma (MCL), myelodysplastic syndromes (MDS), and Waldenstrom macroglobulinemia (WM), all presented by expert faculty. Attendees can receive up to 5.0 AMA PRA Category 1 CreditsTM for physicians, 5.0 ANCC contact hours for nurses, or 5.0 ACPE contact hours for pharmacists. ODACon is chaired by Amir Fathi, MD, Associate Professor of Medicine at Harvard Medical School and Director of the Center for Leukemia at Massachusetts General Hospital. Dr. Fathi will highlight individualized treatment selection for patients with ALL, as well as the latest efficacy and safety data for novel therapeutic strategies. Louis Diehl, MD, Profess...
i3 Health's study focusing on the effectiveness of an online continuing medical education (CME)/nursing continuing professional development (NCPD)–approved activity to improve clinicians' knowledge of therapeutic advances in T-cell lymphoma (TCL) has been published as a 63rd American Society of Hematology (ASH) Annual Meeting & Exposition online abstract. ...

ROCHELLE PARK, NJ––September 28, 2021 – Oncology Data AdvisorTM, a multimedia site that publishes expert perspectives, news, and original research to foster improved understanding of emerging data in oncology, has announced the addition of an editorial board that will help plan and create relevant content for the multidisciplinary cancer care team.

Subscribe

Get the latest updates delivered to your inbox!

Follow Us

Copyright © 2022 Oncology Data Advisor. All rights reserved.